Adaptation of a diverse simian immunodeficiency virus population to a new host is revealed through a systematic approach to identify amino acid sites under selection

Molecular Biology and Evolution

Volumn 24, Issue 3, 2007, Pages 660-669

  Vanderford, Thomas H ^a   Demma, Linda J ^a,d   Feinberg, Mark B ^a,b,e   Staprans, Silvija I ^a,b,e   Logsdon Jr , John M ^a,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cercocebus atys; Macaca mulatta; Quasispecies; Selection; SIV; Zoonosis

Indexed keywords

AMINO ACID;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCEPTUAL FRAMEWORK; EVOLUTIONARY ADAPTATION; GENETIC SELECTION; GENETIC VARIABILITY; GLYCOSYLATION; INOCULATION; NONHUMAN; POPULATION GENETICS; POPULATION STRUCTURE; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADAPTATION, BIOLOGICAL; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CERCOCEBUS ATYS; EVOLUTION, MOLECULAR; GENES, VIRAL; GENETICS, POPULATION; LIKELIHOOD FUNCTIONS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION (GENETICS); SEQUENCE ANALYSIS, DNA; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; VARIATION (GENETICS);

CERCOCEBUS TORQUATUS ATYS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33847636596     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msl194     Document Type: Article

References (44)

1. Apetrei C, Kaur A, Lerche NW, et al. (19 co-authors). 2005. Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol. 79(14):8991-9005.
2. Apetrei C, Lerche NW, Pandrea I, Gormus B, Silvestri G, Kaur A, Robertson DL, Hardcastle J, Lackner AA, Marx PA. 2006. Kuru experiments triggered the emergence of pathogenic SIV-mac. Aids. 20(3):317-321.
3. Brenchley JM, Schacker TW, Ruff LE, et al. (11 co-authors). 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 200(6):749-759.
4. Broussard SR, Staprans SI, White R, Whitehead EM, Feinberg MB, Allan JS. 2001. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol. 75:2262-2275.
5. Demma LJ, Logsdon JM Jr, Vanderford TH, Feinberg MB, Staprans SI. 2005. SIV quasispecies adaptation to a simian new host. PLoS Path. 1(1):e3.
6. Demma LJ, Vanderford TH, Logsdon JM Jr, Feinberg MB, Staprans SI. 2006. Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host. Retrovirology. 3:19.
7. Fourment M, Gibbs MJ. 2006. PATRISTIC: a program for calculating patristic distances and graphically comparing the components of genetic change. BMC Evol Biol. 6:1.
8. Frost SDW, Wrin T, Smith DM, et al. (12 co-authors). 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci USA. 102(51):18514-18519.
9. Gao F, Bailes E, Robertson DL, et al. (12 co-authors). 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 397:436-441.
10. Goldstein S, Ourmanov I, Brown CR, Plishka R, Buckler-White A, Byrum R, Hirsch VM. 2005. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates. J Virol. 79(8):5153-5162.
11. Hahn BH, Shaw GM, Cock KMD, Sharp PM. 2000. AIDS as a zoonosis: scientific and public health implications. Science. 287:607-614.
12. Hey J, Wakeley J. 1997. A coalescent estimator of the population recombination rate. Genetics. 145(3):833-846.
13. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR. 1989. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature. 339:389-392.
14. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373: 123-126.
15. Holmes KV. 2005. Structural biology. Adaptation of SARS coronavirus to humans. Science. 309(5742):1822-1823.
16. Huelsenbeck JP, Ronquist F. 2001. MrBayes: Bayesian inference of phylogenetic trees. Bioinformatics. 17:754-755.
17. Ito T, Couceiro JN, Kelm S, et al. (11 co-authors). 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol. 72(9):7367-7373.
18. Kosakovsky Pond SL, Frost SD, Muse SV. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics. 21(5):676-679.
19. Kosakovsky Pond SL, Frost SD. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol. 22(5):1208-1222.
20. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska JT, Gonzalez JP, Swanepoel R. 2005. Fruit bats as reservoirs of Ebola virus. Nature. 438(7068):575-576.
21. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 434(7037):1148-1152.
22. Maciukenas M. 1994. Treetool 2.0.2 [Internet]. Ribosomal RNA Database Project, University of Illinois. Available from: http://iubio.bio.indiana.edu: 7780/archive/00000441/.
23. Maddison WP, Maddison DR. 1989. Interactive analysis of phylogeny and character evolution using the computer program MacClade. Folia Primatol. 53(1-4):190-202.
24. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 424(6944):99-103.
25. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 434(7037):1093-1097.
26. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 200(6):761-770.
27. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 279:1223-1227.
28. Moya A, Holmes EC, Gonzalez-Candelas F. 2004. The population genetics and evolutionary epidemiology of RNA viruses. Nat Rev Microbiol. 2(4):279-288.
29. Palese P. 2004. Influenza: old and new threats. Nat Med. 10 (Suppl 12):S82-S87.
30. Pandrea I, Apetrei C, Gordon S, et al. (14 co-authors). September 26, 2006. Paucity of CD4+CCR5+ T-cells is a typical feature of natural SIV hosts. Blood. 10.1182/blood-2006-05-024364.
31. Parrish CR, Kawaoka Y. 2005. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Ann Rev Microbiol. 59(1):553-586.
32. Posada D, Crandall KA. 1998. Modeltest: testing the model of DNA substitution. Bioinformatics. 14(9):817-818.
33. Qu X-X, Hao P, Song X-J, et al. (19 co-authors). 2005. Identifi-cation of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J Biol Chem. 280(33):29588-29595.
34. Regoes RR, Antia R, Garber DA, Silvestri G, Feinberg MB, Staprans SI. 2004. Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection. J Virol. 78(9):4866-4875.
35. Rybarczyk BJ, Montefiori D, Johnson PR, West A, Johnston RE, Swanstrom R. 2004. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques. J Virol. 78(7):3561-3571.
36. Sheridan I, Pybus OG, Holmes EC, Klenerman P. 2004. High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol. 78(7):3447-3454.
37. Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser W, Garber D, McClure H, Feinberg MB, Staprans SI. 2005. Divergent host responses during primary SIVsmm infection of natural mangabey and non-natural rhesus macaque hosts. J Virol. 79:4043-4054.
38. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science. 305(5682):371-376.
39. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 427(6977):848-853.
40. Swofford DL. 2002. PAUP*. Phylogenetic analysis using parsimony (*and other methods). Version 4.0. Sunderland (MA): Sinauer Associates.
41. Wang M, Yan M, Xu H, et al. (25 co-authors). 2005. SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis. 11(12):1860-1865.
42. Webby R, Hoffmann E, Webster R. 2004. Molecular constraints to interspecies transmission of viral pathogens. Nat Med. 10 (Suppl 12):S77-S81.
43. Wei X, Decker JM, Wang S, et al. (15 co-authors). 2003. Antibody neutralization and escape by HIV-1. Nature. 422:307-311.
44. Williamson S. 2003. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol. 20(8):1318-1325.